Avian embryo experiments proved an ingrowth model for the coronary artery connections with the aorta. However, whether a similar mechanism applies to the mammalian heart still remains unclear. Here we analyzed how the main coronary arteries and their orifices form during murine heart development. Apelin (Apln) is expressed in coronary vascular endothelial cells including peritruncal endothelial cells. By immunostaining, however, we did not find Apln expression in endothelial cells of the aorta during the period of coronary vessel development (E10.5 to E15.5). As a result of this unique expression difference, Apln CreERT2/+ genetically labels nascent coronary vessels forming on the heart, but not the aorta endothelium when pulse activated by tamoxifen injection at E10.5. This allowed us to define the temporal contribution of these distinct endothelial cell populations to formation of the murine coronary artery orifice. We found that the peritruncal endothelial cells were recruited to form the coronary artery orifices. These cells penetrate the wall of aorta and take up residence in the aortic sinus of valsalva. In conclusion, main coronary arteries and their orifices form through the recruitment and vascular remodeling of peritruncal endothelial cells in mammalian heart.
Introduction
Coronary arteries connect to the aorta and supply oxygenated blood to the heart muscle [1] [2] [3] . For most of the last century, the coronary arteries were believed to grow out of the aorta, forming the coronary artery orifices and proximal coronary arteries by sprouting angiogenesis [4, 5] . Experiments in avian embryos later questioned this dogma and suggested a reverse model in which coronary arteries forms from the preliminary coronary plexuses of the developing heart and grow into the aortic wall to form the coronary orifices and proximal coronary arteries [6] [7] [8] [9] . In the key experiment, quail proepicardium was transplanted into the pericardial cavity of chicken embryos. Quail endothelial cells from transplantation were found to form the proximal part of the two main coronary arteries connecting aorta endothelium [8] . However, at present there is no data about whether a similar mechanism accounts for the coronary artery orifice formation in mammalian hearts. In large part, this has been due to the lack of proper genetic tools that distinguish coronary from aortic endothelia.
Here, we took advantage of a new inducible Cre genetic lineage tracing tool, Apln CreERT2 , that allows us to distinguish endothelial cells of the coronary vasculature of the developing heart from those of the aortic wall. Our data demonstrate that the coronary artery stems and orifices are largely derived from the coronary vasculature of the developing heart, which grow into the aorta to communicate with the systemic blood supply.
Methods

Ethics Statement
This study was carried out in strict accordance with the guidelines in the Institutional Animal Care and Use Committee (IACUC) of the Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Approved protocol number 2011-AN-2).
Mice
Apln
CreERT2/+ , Apln LacZ/+ , Wt1
CreERT2/+ , and Rosa26 RFP/+ mice were described previously [10] [11] [12] [13] . All mice were used in accordance with the guidelines of the Institutional Animal Care and Use Committee of the Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. Mice were maintained on a C129/C57BL6/J mixed background. Tamoxifen (Sigma) was dissolved in corn oil (0.1 -0.15 mg/g). and introduced by gavage at the indicated time The date of the vaginal plug was designated as embryonic day 0.5 (E0.5).
Immunostaining
Immunostaining was conducted as previously described [14] . Briefly, embryonic and adult hearts were fixed in 4% PFA in PBS for 30 min and 2 h at 4°C, respectively. After washing in PBS, hearts were dehydrated in 30% sucrose at 4°C overnight. Specimens were embedded in OCT and quickly frozen in dry ice. Frozen tissues were sectioned at 10 μm thickness. Sections were blocked with 5% normal donkey serum in 0.2%Triton X-100 PBS for 30 min at room temperature. The specimens were incubated with rabbit anti-estrogen receptor (ESR, Abcam, ab27595), mouse anti-alpha smooth muscle actin (aSMA, Sigma, F3777), rabbit anti-RFP (Rockland, 600-401-379), rabbit anti-beta Gal (MP, 55976) and rat anti-PECAM antibodies (BD Pharmingen, 553370) in a humid chamber at 4°C overnight, and then washed three times in PBS for 5 min. Alexa Fluor secondary antibodies (Invitrogen) were added for 30 min at room temperature. HRP-conjugated or biotin-conjugated antibodies with tyramide signal amplification (PerkinElmer) were used to enhance signals of weakly staining antibodies. After a final rinse in PBS, the specimens were counterstained with 4', 6-diamidino-2-phenylindole (DAPI) and coverslipped. Images were acquired using a Zeiss LSM510 confocal microscope, a Leica M165 FC stereo microscope, and a Olympus BX53 microscope.
X-gal staining
X-gal staining was conducted as previously described with some modifications [15] . Embryos were dissected in PBS and fixed with 0.2% glutaraldehyde in PBS for 30 minutes. Then hearts or thoraxes of embryos were washed in X-gal washing buffer and stained in X-gal staining solution (1mg/ml X-gal) at 37°C over night. Subsequently, embryos were washed 3 times in washing buffer. Wholemount pictures were taken using a stereo microscope (Leica, M165 FC).
Results
Apln is specifically expressed in vascular endothelial cells of embryonic and adult hearts [10, 16] . To examine Apln expression in embryos, we used Apln CreERT2/+ and Apln LacZ/+ knockin mouse lines [10, 12] , and stained for estrogen receptor (ESR) or beta-galactosidase as surrogates for Apln expression. ESR staining on embryonic sections and wholemount hearts showed Apln is specifically expressed in vascular endothelial cells at examined stages (E10.5 to E15.5, Figure 1A -1C), which is in consistence with previous work [10, 12, 16] . ESR staining of Apln CreERT2/+ embryonic hearts showed that Apln is not expressed in endothelia of aorta through all examined stages of coronary development (E10.5 to E15.5, Figure 1A -C). To confirm the immunostaining result, we used in situ hybridization on wild type hearts from E10.5 to E13.5 and found Apln is not expressed in endothelium of outflow tract or aorta at these stages ( Figure 1D ). These results were independently reinforced by wholemount X-gal staining of Apln LacZ/+ embryonic hearts, which did not detect Apln-driven LacZ expression in aortic endothelium ( Figure 1E-1G) .
Positive Apln expression in the developing coronary plexus over the heart and negative Apln expression in aortic endothelium indicated that Apln CreERT2/+ lineage tracing would be informative on the contribution of the early coronary plexus of the developing heart to the coronary artery stems and orifices ( Figure 2A) . Based on models proposed by previous avian work [4] [5] [6] [7] [8] , we evaluated two models for coronary stem and orifice formation in mouse developing heart: an outgrowth model in which the unlabeled aortic endothelium spreads out to form the coronary artery stems and orifices through angiogenesis; and an ingrowth model in which AplnCreERT2-labeled peritruncal coronary endothelial cells are first recruited into the aorta wall and then coalesce and remodel to form the proximal coronary arteries and their orifices in the sinuses of Valsalva of the aorta ( Figure 2B) . For all studies, we induced Cre-mediated recombination by E10.5 tamoxifen injection, which specifically label coronary vascular plexus by genetic marker RFP at early stages (before E12.5) [12] . By immunostaining of the genetic lineage tracing marker (RFP) and endothelial cell marker (PECAM) on E12.5 Apln CreERT2/+ ;Rosa26 RFP/+ heart sections, we detected the genetically labeled peritruncal capillary plexus around the aorta, especially in the region close to the right and left facing aortic sinuses [17] (Figure 2C ). From E13.5 to postnatal stages, the main coronary arteries gradually emerge, and they become readily detectable after E14.5 ( Figure 2D ). By E10.5 pulse tamoxifen induction, almost all endothelium of the main coronary arteries and their branches were genetically labeled, as detected at later stages ( Figure 2D ), suggesting that endothelial cells were first recruited to the peritruncal region where they contributed to form the proximal coronary arteries. postnatal day 7 (P7), P28 stages ( Figure 2E and Figure 4 and data not shown). The labeled coronary endothelial cells spanned the thick aortic wall, constituting virtually the entire coronary orifice (Figure 4 ). To provide further evidence at single cell resolution, we sectioned these Apln CreERT2/+ ;Rosa26 RFP/+ hearts for immunostaining of genetic and vascular markers. By studying serial sections, we verified that the endothelium lining the orifices in the aorta was derived from early Apln + coronary vascular plexus ( Figure 5 ).
Discussion
Previous work based on avian models suggested that the endothelium of the coronary artery originates from (pro)epicardium [18, 19] and sinus Venosus [8] , and eventually grows into the aorta, thereby forming the coronary arterial orifices [6, 7, 20] . However, studies of coronary artery formation in mammals do not often lead to same conclusions, so that it is important to revisit this question in mammals. Our work is consistent with the coronary artery ingrowth model, and extends this model by showing that the peritruncal endothelial cells constitute virtually all coronary artery stems and two coronary orifices in the aorta. Lineage tracing data also suggested that coronary artery stems initially form by recruitment of peritruncal endothelial cells, subsequently followed by a remodeling and maturation process with addition of smooth muscle cells.
The peritruncal coronary plexus forms at E12.5, providing multiple vessels that could potentially connect to the aorta. In both chicken and mouse models, peritruncal vascular endothelial cells penetrated the facing left and right sinuses. Only these two coronary artery strands penetrating the aortic wall finally develop into the coronary artery stems and orifices. In some chicken embryos, several endothelial strands penetrated the posterior (noncoronary) sinus, and they eventually disappear [8, 9] . The regional signaling that governs the establishment, penetration, maintenance, and growth of these two coronary artery strands remains largely unknown. It was indicated by chicken model that proper orifice development is associated with penetration of epicardiumderived cells (EPDCs) that produce Fas ligand as an apoptotic inductor at sites of coronary ingrowth [20] . Since disruption of EPDCs contribution show abnormalities in coronary ingrowth and orifice formation [20] and also EPDCs exhibit proangiogenic properties [14] , it would be important to investigate the secreting profile of penetrating EPDCs for peritruncal vascular angiogenesis. Previous work showed that EPDCs contribute to most smooth muscle cell fate [13, 21, 22] , we reasoned that their in situ trans-differentiation into smooth muscle could be responsible for the consolidation of the main arteries. Alternatively, possible cues for guidance of ingrowth and subsequent persistence of the proximal coronary artery stems could be the parasympathic innervation by neural crest cells, as ablation of neural crest cells causes abnormalities in coronary orifice formation [23] .
Our study provided a useful tool for genetically marking the coronary plexus and subsequent coronary artery stems and orifices, allowing visualization of the entire process of coronary artery orifice development under normal and pathological conditions such as anomalous origin of the right or left coronary artery (AORCA or AOLCA) [24, 25] . The ability to monitor this process will facilitate future mechanistic studies of the signals that govern it. In addition, differential labeling of nascent versus established vasculature by Apln
CreERT2 will likely make it useful to study vascular growth patterns in other organs or tissues under normal and pathophysiological conditions such as ischemic disease, vascular regeneration and tumor angiogenesis. 
